PNC Financial Services Group Inc. boosted its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 22.4% in the third quarter, Holdings Channel reports. The institutional investor owned 25,955 shares of the company’s stock after buying an additional 4,745 shares during the period. PNC Financial Services Group Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $374,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Raymond James Financial Services Advisors Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 15.8% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 69,130 shares of the company’s stock valued at $1,387,000 after acquiring an additional 9,413 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in BlackRock Health Sciences Term Trust by 37.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 23,480 shares of the company’s stock worth $471,000 after buying an additional 6,407 shares during the period. First Trust Advisors LP grew its position in shares of BlackRock Health Sciences Term Trust by 8.3% in the 1st quarter. First Trust Advisors LP now owns 86,674 shares of the company’s stock valued at $1,739,000 after buying an additional 6,654 shares during the last quarter. Quantedge Capital Pte Ltd increased its stake in shares of BlackRock Health Sciences Term Trust by 448.0% in the first quarter. Quantedge Capital Pte Ltd now owns 69,600 shares of the company’s stock valued at $1,396,000 after buying an additional 56,900 shares during the period. Finally, City of London Investment Management Co. Ltd. raised its position in shares of BlackRock Health Sciences Term Trust by 45.6% during the first quarter. City of London Investment Management Co. Ltd. now owns 218,424 shares of the company’s stock worth $4,376,000 after acquiring an additional 68,452 shares during the last quarter.
Insider Transactions at BlackRock Health Sciences Term Trust
In other news, major shareholder Saba Capital Management, L.P. bought 347,814 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The shares were acquired at an average price of 15.26 per share, for a total transaction of 5,307,641.64. Following the completion of the acquisition, the insider now directly owns 18,048,897 shares in the company, valued at 275,426,168.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders bought a total of 3,236,141 shares of company stock worth $48,908,997 over the last three months.
BlackRock Health Sciences Term Trust Trading Up 1.2 %
Shares of BMEZ stock opened at 16.51 on Friday. The business’s 50 day simple moving average is 15.43 and its 200 day simple moving average is 14.70. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.95.
BlackRock Health Sciences Term Trust Cuts Dividend
The company also recently disclosed a monthly dividend, which was paid on Thursday, February 29th. Stockholders of record on Thursday, February 15th were paid a $0.09 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 6.54%. The ex-dividend date was Wednesday, February 14th.
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: americanbankingnews.com
